Sanofi gains FDA clearance for Gaucher disease pill
BioPharma DiveDelilah AlvaradoNovember 19, 2026
The approval culminates a winding development journey for Infilbray, and provides Sanofi with a new source of income ahead of Dupixent s looming patent expiration.
